MiMedx CEO Parker H. “Pete” Petit and COO and President William C. “Bill” Taylor have resigned as a board-directed independent investigation continues into accounting practices, Marietta, Ga.–based MiMedx (Nasdaq: MDXG) announced today.
Petit and Taylor’s exit comes after recent departures of MiMedx’s CFO and corporate controller and treasurer. In addition to the resignations of top brass, the regenerative and therapeutic biologics company now plans to restate all of its earnings reports going back to 2012. The company says it is cooperating with U.S. Securities and Exchange Comission and Department of Justice investigations.
Get the full story on our sister site Drug Delivery Business News.
The post MiMedx top brass resign amid internal accounting investigation appeared first on MassDevice.
from MassDevice https://ift.tt/2tWEAZz
Cap comentari:
Publica un comentari a l'entrada